1. Home
  2. TELO vs CSPI Comparison

TELO vs CSPI Comparison

Compare TELO & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • CSPI
  • Stock Information
  • Founded
  • TELO 2021
  • CSPI 1968
  • Country
  • TELO United States
  • CSPI United States
  • Employees
  • TELO N/A
  • CSPI N/A
  • Industry
  • TELO
  • CSPI EDP Services
  • Sector
  • TELO
  • CSPI Technology
  • Exchange
  • TELO NYSE
  • CSPI Nasdaq
  • Market Cap
  • TELO 154.1M
  • CSPI 174.4M
  • IPO Year
  • TELO 2024
  • CSPI 1987
  • Fundamental
  • Price
  • TELO $3.91
  • CSPI $17.31
  • Analyst Decision
  • TELO
  • CSPI
  • Analyst Count
  • TELO 0
  • CSPI 0
  • Target Price
  • TELO N/A
  • CSPI N/A
  • AVG Volume (30 Days)
  • TELO 122.3K
  • CSPI 37.9K
  • Earning Date
  • TELO 02-04-2025
  • CSPI 02-10-2025
  • Dividend Yield
  • TELO N/A
  • CSPI 0.69%
  • EPS Growth
  • TELO N/A
  • CSPI N/A
  • EPS
  • TELO N/A
  • CSPI 0.02
  • Revenue
  • TELO N/A
  • CSPI $55,514,000.00
  • Revenue This Year
  • TELO N/A
  • CSPI N/A
  • Revenue Next Year
  • TELO N/A
  • CSPI N/A
  • P/E Ratio
  • TELO N/A
  • CSPI $924.49
  • Revenue Growth
  • TELO N/A
  • CSPI N/A
  • 52 Week Low
  • TELO $3.11
  • CSPI $10.76
  • 52 Week High
  • TELO $9.54
  • CSPI $29.93
  • Technical
  • Relative Strength Index (RSI)
  • TELO 40.31
  • CSPI 43.99
  • Support Level
  • TELO $3.75
  • CSPI $17.22
  • Resistance Level
  • TELO $4.83
  • CSPI $20.39
  • Average True Range (ATR)
  • TELO 0.32
  • CSPI 1.56
  • MACD
  • TELO -0.05
  • CSPI -0.32
  • Stochastic Oscillator
  • TELO 13.01
  • CSPI 1.90

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

Share on Social Networks: